WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.
The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.
advertisement
The negotiated prices won’t take effect until 2026.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Lawmakers consider Medicare pay reforms for doctors
Next article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： After affirmative action ruling, medical educators look to 'holistic review'
